Ahmad Ali Mortazavi Insider Profile
4 Followers
Ahmad Ali Mortazavi, Chief Executive at Silence Therapeutics, holds 1.94M shares in Silence Therapeutics (Ticker: SLN), holds 50.94M shares in E Therapeutics (Ticker: GB:ETX), holds 1.94M shares in Silence Therapeutics (Ticker: GB:SLN).
Ahmad Ali Mortazavi's Trading History
| ETXE Therapeutics | Oct 26, 2021 | ― | Informative Buy | 100.38K | £4.58M | |
| SLNSilence Therapeutics | Apr 19, 2016 | ― | Informative Buy | 200.00K | £10.37M | |
| SLNSilence Therapeutics | ― | Chief Executive | ― | $38.36M |
You May Also Like
Ahmad Ali Mortazavi insider profile FAQ
What is the percentage of profitable transactions made by Ahmad Ali Mortazavi?
The percentage of profitable transactions made by Ahmad Ali Mortazavi is 50%.
What is the average return per transaction made by Ahmad Ali Mortazavi?
The average return per transaction made by Ahmad Ali Mortazavi is 2.60%.
What stocks does Ahmad Ali Mortazavi hold?
Ahmad Ali Mortazavi holds: SLN, GB:ETX, GB:SLN stocks.
What was Ahmad Ali Mortazavi's most profitable transaction?
Ahmad Ali Mortazavi’s most profitable transaction was an Informative Buy of GB:ETX stock on July 15, 2020. The return on the trade was 70.10%.
What is Ahmad Ali Mortazavi's role in Silence Therapeutics?
Ahmad Ali Mortazavi's role in Silence Therapeutics is Chief Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
